Bad news for big pharma
Inexpensive ’polypill’ can cut the risk of strokes and heart disease by 50 per cent
A new study by a Canadian researcher published it British medical journal The Lancet suggests that a cheap five-in-one combination "polypill" of aspirin and cholesterol and blood pressure-lowering drugs can cut the risk of strokes and heart disease by 50 per cent. If approved for wider use, the “polypill” would reduce the need of many patients to take multiple and expensive drugs to treat such illnesses. "These drugs are off-patent and cost pennies," notes one health specialist.
Related Posts
Life
Debating the pros and cons of Daylight Saving Time
Ahead of the end of this year’s daylight saving on Nov. 7, Shannon Proudfoot breaks down the pros and cons of the increasingly unpopular practice
General
Maclean’s 2022 Student Survey Contest Rules
CONTEST RULES (the “Official Rules”) Maclean’s Student Survey 2022 Contest (the “Contest”) WHO ARE THE SPONSORS?...
General
Maclean’s Registration wall FAQ
You can read five Macleans.ca articles every 30 days. To read more, you must create an account or log in to an existing...
Get the Best of Maclean’s straight to your inbox.
Sign up for news, commentary and analysis. Join 60,000+ Canadian readers.